文献速递肺栓塞与肺血管病呼吸道感染

COVID-19相关肺血栓形成与血栓栓塞

Pulmonary Thrombosis and Thromboembolism in COVID-19.
PubMed 文献 · Chest · 2021-06-19

本文综述COVID-19相关肺血栓形成与血栓栓塞的流行病学、病理生理、诊断和治疗。COVID-19患者即使接受预防性抗凝,肺血栓风险仍显著增加,机制涉及高凝状态和直接血管内皮损伤;肺栓塞与COVID-19肺炎症状重叠使诊断困难,许多医院已采用高于标准预防的积极抗凝方案。

要点

  • COVID-19患者肺血栓风险显著增加,即使接受预防性抗凝亦然。
  • 肺栓塞与COVID-19肺炎症状重叠,诊断需警惕。
  • 部分医院已采用高于标准预防的积极抗凝方案。

核心结论

  • COVID-19与肺血栓形成和血栓栓塞风险显著增加相关,即使患者接受预防性抗凝。

研究设计与样本

  • 本文为综述,讨论COVID-19肺血栓形成与血栓栓塞的流行病学、病理生理、诊断和治疗。

主要发现

  • COVID-19中血栓形成倾向可能由至少两个不同但相互关联的过程驱动:导致大血管血栓形成和血栓栓塞的高凝状态,以及导致原位微血管血栓形成的直接血管和内皮损伤。
  • 肺血栓形成的存在可能解释部分COVID-19肺炎患者低氧血症与肺顺应性损害不成比例。
  • 肺栓塞与COVID-19肺炎共享许多体征和症状,使COVID-19患者中肺栓塞诊断具有挑战性。
  • 鉴于重症COVID-19相关高死亡率和发病率,以及疾病部分方面可能由血栓形成驱动的担忧,许多医院系统已实施高于标准VTE预防的积极抗凝方案。

临床怎么用

  • 临床应关注COVID-19患者肺血栓形成风险,即使已接受预防性抗凝。
  • 对COVID-19肺炎患者出现与肺顺应性损害不成比例的低氧血症时,应考虑肺血栓形成可能。
  • 诊断肺栓塞时需注意其与COVID-19肺炎症状重叠,避免漏诊。
  • 部分医院系统已采用高于标准VTE预防的积极抗凝方案,临床可参考但需个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COVID-19, the disease responsible for the devastating pandemic that began at the end of 2019, has been associated with a significantly increased risk of pulmonary thrombosis, even in patients receiving prophylactic anticoagulation. The predilection for thrombosis in COVID-19 may be driven by at least two distinct, but interrelated, processes: a hypercoagulable state responsible for large-vessel thrombosis and thromboembolism and direct vascular and endothelial injury responsible for in situ microvascular thrombosis. The presence of pulmonary thrombosis may explain why hypoxemia is out of proportion to impairment in lung compliance in some patients with COVID-19 pneumonia. Because pulmonary embolism (PE) and COVID-19 pneumonia share many signs and symptoms, diagnosing PE in patients with COVID-19 can be challenging. Given the high mortality and morbidity associated with severe COVID-19 and the concern that aspects of the disease may be driven by thrombosis, many hospital systems have instituted aggressive anticoagulation protocols above standard VTE prophylaxis. In this review, the epidemiologic and pathophysiologic features, diagnosis, and treatment of COVID-19 pulmonary thrombosis and thromboembolism are discussed.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Poor HD. Pulmonary Thrombosis and Thromboembolism in COVID-19. Chest. 2021. PMID: 34153340. doi:10.1016/j.chest.2021.06.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。